Zhengjie Chen

Title: Innovations of Zhengjie Chen

Introduction

Zhengjie Chen is a notable inventor based in Taizhou, China. He has made significant contributions to the field of microbiology and pharmaceuticals. With a total of four patents to his name, Chen has focused on developing methods for producing important compounds.

Latest Patents

Among his latest patents, Zhengjie Chen has developed methods for producing milbemycin A4 and milbemycin A3. The patent for milbemycin A4 involves a strain designated as HS7522, which is deposited in the China General Microbiological Culture Collection Center under accession number CGMCC No. 9671 as of September 16, 2014. Similarly, the patent for milbemycin A3 utilizes a strain known as HS7523, which is also deposited in the same center with accession number CGMCC No. 9672 on the same date.

Career Highlights

Throughout his career, Zhengjie Chen has worked with various companies, including Global Strategic Connections, LLC and Zhejiang Hisun Pharmaceutical Co., Ltd. His work has contributed to advancements in pharmaceutical research and development.

Collaborations

Zhengjie Chen has collaborated with notable individuals in his field, including Hua Bai and Peijie Yang. These collaborations have further enhanced his research and innovation efforts.

Conclusion

Zhengjie Chen's contributions to the field of microbiology and pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the industry positively.